|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of prenatal diagnosis on the prevalence of live birth with Down syndrome in the eastern half of Switezerland 1980-1996显示文摘 | Binkert F Mutter M ScbinzeL A | 2002 | Swiss Med Wkly2002，132，3334： | 1 |
| 2 | The discovery of N-ethoxy ] -4-pyrimidinyl ] -N'-propylsulfamide ( Maciten- tan), an orally active, potent dual endothelin receptor antago- nist 显示文摘 | BOLLI M H BOSS C BINKERT C | 2012 | J Med Chem2012，55，17： | 1 |
| 3 | Pharmacology of ma- citentan,an orally active tissue-targeting dual endothelin receptor antagonist显示文摘 | Iglarz M Binkert C Morrison K | | J Pharmacol Exp Ther0，327，3： | 1 |
| 4 | The expression of urotensinⅡreceptor(U2R)is up-regulated by interferon-gamma显示文摘 | Birker-Robaczewska M Binkert C Nayler O | 2003 | J Recept Signal Transduct Res2003，23，4： | 1 |
| 5 | The discovery of N- ethoxy ] -4- pyrimidinyl ] - N'-propylsulfamide (macitentan) ,an orally active, potent dual endothelin receptor antagonist 显示文摘 | BOLLI M H BOSS C BINKERT C | 2012 | J Med Chem2012，55，： | 1 |
| 6 | Pharmacology of the Urotensin-Ⅱ receptor antagonist palosuran (ACT-058362;1--3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt):First demonstration of a pathophysiological role of the Urotensin system显示文摘 | Clozel M Binkert C Birker-Robaczewska M | 2004 | J Pharmacol Exp Ther2004，14，： | 1 |
| 7 | Impact of prenatal diagnosis on the prevalence of live birth with Down syndrome in the eastern half of Switzerland 1980 -1996显示文摘 | Binkert Mutter M Scbinzel A | 2002 | Swiss Med Wkly2002，132，： | 1 |
| 8 | Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type Ⅱ receptor mimic and cytokine antagonist显示文摘 | Demetriou M Binkert C Sukhu B | | 0，，22： | 1 |
| 9 | A molecular study of X isoehromosomes: parental origin, centromeric structure, and mechanisms of formation显示文摘 | Lorda-Sanchez I Binkert F Maeehler M | 1991 | Am J Hum Genet1991，49，5： | 1 |
| 10 | Regulation of osteogenesis by fetuin显示文摘 | Binkert C Demetriou M Sukhu B | | 0，，40： | 1 |
| 11 | Osteoid osteoma: technique of computed tomography-controlled percutaneous resection using standard equipment available in most orthopaedic operating rooms 显示文摘 | Buhler M Binkert C Exner GU | 2001 | Arce Orthop Trauma Surg2001，121，： | 1 |
| 12 | CT arthrography of the glenohumeral joint: CT fluoroscopy versus conventional CT and fluoroscopy comparison of image-guidance techniques显示文摘 | Binkert C A Verdtn F R Zanetti M | 2003 | Radiology2003，229，1： | 1 |
| 13 | Pharmacology of macitentan,an orally active tissue-targeting dual endothelin receptor antagonist显示文摘 | Iglarz M Binkert C Morrison K | | 0，，03： | 1 |
| 14 | MR arthrography of the glenohumeral joint:two concentrations of gadoteridol versus Ringer solution as intraarticular contrast material显示文摘 | Binkert CA Zanetti M Gerber C | 2001 | Radiology2001，220，： | 1 |
| 15 | Pharmacology of the urotensin-Ⅱ receptor antagonist palosuran: first demonstration of apathophysiological role of the urotensin system 显示文摘 | CLOZEL M BINKERT C BIRKER-ROBACZEWSKA M | 2004 | J Pharmacol Exp Ther2004，311，1： | 1 |
| 16 | Fetuin/c2-HS glyeoprotein is a transforming growth factor-13type II receptor mimic and cytokine an- tagonist显示文摘 | Demetriou M Binkert C Sukhu B | 1996 | J Biol Chem1996，271，12： | 1 |
| 17 | MR morphology of alar ligaments and occipitoatlantoaxial joints: study in 50 asymptomatic subjects显示文摘 | Pfirrmann CW Binkert CA Zanetti M | 2001 | Radiology2001，218，1： | 1 |
| 18 | Pharmacology of macitentan,an orally active tissue-targeting dual endothelin receptor antagonist显示文摘 | Iglarz M Binkert C Morrison K | 2008 | J Pharmacol Exp Ther2008，327，： | 1 |
| 19 | The UVR8 UV-B Pho-toreceptor :Perception,Signaling and Response显示文摘 | Tilbrook K Arongaus AB Binkert M | 2013 | ArabidopsisBook2013，，： | 1 |
| 20 | Pharmacology of macitentan, an orally active tissue- targeting dual endothelin receptor antagonist显示文摘 | IGLARZ M BINKERT C MORRISON K et ol | 2008 | J Pharmacol Exp Ther2008，327，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员